| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Maze Therapeutics, Inc. | CSBO | Common Stock | 10,503 | $480,237 | $45.72 | 27 Feb 2026 | Direct |
| Maze Therapeutics, Inc. | CSBO | Stock Option (Right to Buy) | 38,000 | 02 Mar 2026 | Direct | ||
| Maze Therapeutics, Inc. | CSBO | Restricted Stock Units | 19,000 | 02 Mar 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MAZE | Maze Therapeutics, Inc. | 27 Feb 2026 | 6 | -$262,573 | 4 | CSBO | 03 Mar 2026, 16:25 |
| MAZE | Maze Therapeutics, Inc. | 29 Jan 2026 | 5 | -$253,840 | 4 | CSBO | 02 Feb 2026, 16:21 |
| MAZE | Maze Therapeutics, Inc. | 29 Dec 2025 | 7 | -$2,185,349 | 4 | CSBO | 31 Dec 2025, 16:24 |
| MAZE | Maze Therapeutics, Inc. | 22 Sep 2025 | 1 | $0 | 4 | CSBO | 24 Sep 2025, 16:26 |
| MAZE | Maze Therapeutics, Inc. | 30 Jan 2025 | 0 | $0 | 3 | CSBO | 30 Jan 2025, 16:19 |